Roche can dump the ITMN collaboration in its entirety and have no further obligations to ITMN. What Roche cannot do is develop one or more PI’s from ITMN while also developing one or more PI’s from other companies.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”